AbGenomics Corp.

AbGenomics Corp.
荷商台醫股份有限公司台灣分公司
+886-2-2627-2707
+886-2-2627-2708

Part of the AbGenomics Group, including AbGenomics International Inc., a clinical-stage biopharmaceutical company located in the San Francisco Bay Area.

Involved in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases, allergy, asthma, transplantation rejection, and cancer.

Lead candidate AbGn-168H (Neihulizumab) has demonstrated the proof of clinical efficacy in Phase II clinical trials for T-cell mediated diseases such as psoriasis and psoriatic arthritis.

2F, No. 36, Lane 358
Juikuang Rd, Neihu
Taipei 114, Taiwan
台北市內湖區瑞光路358巷36號2F
2000
– na –

Send Message to listing owner

AbGenomics Corp.